| Quarter (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| 13F holders | Current |
|---|---|
| Total holders | 34 |
| Opened positions | 9 |
| Closed positions | 12 |
| Increased positions | 5 |
| Reduced positions | 6 |
| 13F shares | Current |
|---|---|
| Total value | 637.80 mm |
| Total shares | 134.50 mm |
| Total puts | 5.10 k |
| Total calls | 75.10 k |
| Total put/call ratio | 0.1 |
| Largest owners | Shares | Value |
|---|---|---|
| Hong Seng Technology | 102.44 mm | $159.80 mm |
| Intracoastal Capital | 19.13 mm | $31.57 mm |
| Biotechnology Value Fund L P | 5.95 mm | $11.78 mm |
| Novartis Pharma | 5.00 mm | $12.60 mm |
| Highbridge Capital Management | 1.01 mm | $214.63 mm |
| Values First Advisors | 166.45 k | $35.62 mm |
| Atria Wealth Solutions | 94.13 k | $20.14 mm |
| LPL Financial | 92.00 k | $19.69 mm |
| Susquehanna International | 87.22 k | $18.53 mm |
| MS Morgan Stanley | 79.10 k | $16.93 mm |
